and Pharmacotherapy = Biomedecine and Pharmacotherapie 165, 115263
Weight loss following dietary interventions and bariatric surgery is associated with changes to the circulating proteome, including proteins related to inflammatory and metabolic pathways 9,10
Compare that to tirzepatide results showing 15-25% body weight reduction, or semaglutide before and after results demonstrating 10-15% reductions
Furthermore, the recent Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) trial reported that semaglutide decreases the risk of major cardiovascular events by 20%, becoming the only antiobesity medication shown to improve cardiovsacular outrcomes in adults with overweight and obesity
Timing and planning are key for those considering aesthetic treatments like semaglutide for weight loss But with so many options available, a common question arises: Can you safely combine these procedures in the lead-up to the holidays
and a discontinued oral GLP-1 programme (danuglipron) that was terminated in late 2023 due to gastrointestinal tolerability issues that prevented adequate dose escalation